

Scientists at the University of North Carolina at Chapel Hill have developed a new drug delivery patch known as the Spatiotemporal On-Demand Patch (SOP), which can receive wireless commands from a smartphone or computer to plan and trigger drug release from individual microneedles. The patch’s thin, soft substrate mimics a Band-Aid and was created to improve user comfort and convenience, as wearability is an important consideration for chronically unwell patients.
The study team, led by Juan Song, PhD, professor of pharmacology at the UNC School of Medicine, and Wubin Bai, PhD, assistant professor of applied physical sciences at the UNC College of Arts and Sciences, tested the SOP in a mouse model, utilizing melatonin microneedles to promote sleep.
This study, published in the journal Nature Communications, paves the way for future research into wirelessly controlled patches that can give on-demand treatments for neurodegenerative illnesses such as Alzheimer’s disease. To that end, the UNC School of Medicine and UNC Health supported a $25,000 pilot experiment to evaluate the SOP in a mouse model of Alzheimer’s disease.
“SOP’s ability to enable joint delivery of multiple drugs could address various aspects of Alzheimer’s Disease, such as reducing beta-amyloid plaques, mitigating neuroinflammation and enhancing cognitive function,” said Bai, a co-senior author of the study
Yihang Wang of the Department of Applied Physical Sciences and Zeka Chen of the Department of Pharmacology collaborated on the open access work “Digital Automation of Transdermal Drug Delivery with High Spatiotemporal Resolution.” According to Bai, the study highlights not only multidisciplinary collaboration but also “passionate involvement of Carolina undergraduate students,” including Priyash Hafiz of the Department of Applied Physical Sciences and Brayden Davis, Will Lipman, Tian Wang, and Sicheng Xing of the UNC/NCSU Joint Department of Biomedical Engineering.
The patch, which has a provisional patent, allows for extremely localized therapy of certain tissues, organs, or regions of the body (less than 1 square millimeter), with medication release occurring within 30 seconds of an electrical input. Patients might wear multiple patches at once, reducing the need for doctor visits or possibly hospitalization for medical treatment.
“The beauty of this device is that it can house dozens, if not hundreds, of concentrated drugs and program their sequential release automatically,” said Song, a UNC Neuroscience Center member. “Rapid drug release can be crucial in emergency situations or when immediate therapeutic action is required.”
The gold-coated microneedles safeguard the medications and nearby tissues. When a low-voltage electrical stimulus is provided through the patch, the gold covering dissolves, exposing the drug-loaded microneedles to the skin and starting the controlled release of the medications.
“This level of specificity ensures precise and customized drug delivery, catering to the needs of different conditions or specific regions of the body,” Wang added. “This offers a novel approach to achieving controlled drug release through a combination of materials science and electrical engineering.”
more recommended stories
Scientists Unveil Next-Gen Eye-Tracking with Unmatched Precision
Eye-tracking technology has long been a.
New Study Questions Fluid Restriction in Heart Failure Management
A groundbreaking study presented at the.
Role of Leptin Signaling in the DMH for Metabolic Regulation
A groundbreaking study from the Pennington.
COVID-19 Vaccines May Lower the Risk of Long COVID by 27%
A recent rapid review suggests that.
3D-Printed Hydrogel for Meniscus Tear Treatment
Meniscus tears are one of the.
Machine Learning Predicts Early Mortality in IBD Patients
A groundbreaking study published in the.
Endometriosis Treatment Advances: Latest Research and Therapy
Recent endometriosis treatment advances are reshaping.
Lung Cancer Screening Gaps Persist Despite Updated Guidelines
A recent study led by researchers.
Altered Knee Movement After ACL Surgery May Trigger Early Osteoarthritis
A recent study published in the.
BRP Peptide for Weight Loss: A Natural Alternative to Ozempic?
The rising obesity epidemic has fueled.
Leave a Comment